Cohort (CHRT) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
11 Jan, 2026Executive summary
Achieved record first-half performance with revenue up 25% to £118.2m and adjusted operating profit up 69% to £10.1m year-over-year, supported by robust cash flow and a record order book.
Order intake of £139.2m exceeded revenue, growing the order book to £541.1m, covering more than 99% of consensus revenue forecasts for the year.
Acquisition of EM Solutions, funded by cash, bank debt, and a £40m placing, will expand product range, technology, and geographic reach, and is expected to be materially accretive to adjusted EPS.
Interim dividend increased by over 10% to 5.25p per share, continuing a progressive dividend policy since IPO.
Employee headcount rose to over 1,400, reflecting confidence in the business pipeline and order book.
Financial highlights
Revenue rose 25% year-over-year to £118.2m; adjusted operating profit up 69% to £10.1m; adjusted EPS increased 93% to 20.00p.
Net margin improved to 8.5% from 6.4% last year; net funds at period end were £37.9m, up from £13.3m a year ago.
Cash inflow from operations was £34.7m, up from £10.5m last year, driven by working capital movements and customer advances.
Interim dividend set at 5.25p per share, up from 4.70p.
Overhead increase reflects investment in headcount, now over 1,400 employees.
Outlook and guidance
Order book of £541.1m covers over 99% of consensus forecast revenue for the full year, with over £120m deliverable in H2.
Second half performance expected to be stronger, especially in Sensors and Effectors; full-year profit expectations maintained.
EM Solutions expected to be materially accretive to adjusted EPS in its first full year.
Net margin for the group targeted to rise to low/mid-teens over 3–5 years.
Tax rate for adjusted earnings guided at 20% (excluding EM Solutions), rising to 21% including EM Solutions for FY25.
Latest events from Cohort
- Record revenue and order book, strong global demand, and robust outlook drive confidence.CHRT
Investor Update3 Feb 2026 - Record results, robust order book, and strong demand support a positive growth outlook.CHRT
H2 20243 Feb 2026 - Acquisition brings new tech, global reach, and strong financial upside in defense markets.CHRT
M&A Announcement13 Jan 2026 - Record revenue, strong order book, and global demand drive positive outlook and margin growth.CHRT
Investor Update12 Jan 2026 - Revenue up 9% to £128.8m, strong order book, and positive outlook for H2.CHRT
H1 202611 Dec 2025 - Record revenue, profit, and order book with strong outlook driven by global defense demand.CHRT
H2 202516 Nov 2025 - Record revenue and profit growth, strong order book, and higher dividend signal robust outlook.CHRT
H2 2025 Pre-Recorded16 Nov 2025 - Record order book and strong growth position Cohort for continued expansion in defence markets.CHRT
Trading Update6 Jun 2025